Kewaunee Scientific Corporation - Common Stock (KEQU)
37.31
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 4th, 5:26 AM EDT
Detailed Quote
Previous Close
37.31
Open
-
Bid
15.00
Ask
58.96
Day's Range
N/A - N/A
52 Week Range
30.82 - 71.33
Volume
17
Market Cap
103.37M
PE Ratio (TTM)
6.281
EPS (TTM)
5.9
Dividend & Yield
N/A (N/A)
1 Month Average Volume
32,131
Chart
About Kewaunee Scientific Corporation - Common Stock (KEQU)
Kewaunee Scientific Corporation is a leading manufacturer of laboratory furniture and equipment, specializing in high-quality, customizable solutions for various scientific and research environments. The company provides a wide range of products, including workstation systems, casework, fume hoods, and other laboratory essentials that are designed to enhance safety, functionality, and efficiency in laboratories, healthcare facilities, educational institutions, and industrial settings. With a focus on innovative designs and responsive customer service, Kewaunee aims to meet the unique needs of clients across diverse sectors, ensuring that their laboratory spaces are optimized for productivity and collaboration. Read More
Kaskela Law LLC announces that it is investigating Kewaunee Scientific Corporation (NASDAQ: KEQU) (“Kewaunee”) on behalf of the company’s shareholders.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation (“Kewaunee Scientific” or “the Company”) (NASDAQ: KEQU) for violations of the securities laws.
Companies Reporting Before The Bell • Ollie's Bargain Outlet (NASDAQ:OLLI) is estimated to report quarterly earnings at $0.44 per share on revenue of $468.55 million.
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
Kewanuee Scientific Corp's (NASDAQ: KEQU) Indian subsidiary has secured a $17.3 million contract from Dangote Oil Refinery Company Limited for laboratory...
Companies Reporting Before The Bell
• Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first quarter.
• Waterdrop (NYSE:WDH) is expected to report...
Companies Reporting Before The Bell
• Northern Technologies (NASDAQ:NTIC) is likely to report quarterly earnings at $0.13 per share on revenue of $14.10 million....
